US-based biotechnology firm Luminex has obtained CE-IVD mark for its qualitative in-vitro diagnostic test, ARIES Norovirus Assay.

The sample-to-answer test uses a real-time polymerase chain reaction (PCR) designed to quickly identify and distinguish norovirus genogroup I and II in stool specimens of people with acute gastroenteritis symptoms.

The assay can be used to simultaneously run a laboratory-developed test (LDT) and in-vitro diagnostic assay (IVD) in a sample-to-answer format at various laboratory shifts during the use of a universal assay protocol.

Luminex Europe managing director Thomas Pracht said: “The ARIES Norovirus Assay offers excellent performance for high confidence in results and reduced hands-on time compared to other molecular assays.

“By enabling rapid and accurate diagnosis even outside office hours, the assay can expedite appropriate infection control measures.”

The Norovirus Assay expands the firm’s ARIES platform of systems that are developed to enhance laboratory efficiency and result accuracy.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
“By enabling rapid and accurate diagnosis even outside office hours, the assay can expedite appropriate infection control measures.”

The systems automate testing steps such as sample preparation and analysis, while providing quick results, and use features such as internal barcode scanning to reduce operator errors.

ARIES products are available with an integrated touchscreen PC, eliminating the necessity of a separate computer, standalone keyboard and mouse.

The ARIES Norovirus Assay belongs to the firm’s gastroenterological testing menu, comprising xTAG Gastrointestinal Pathogen Panel (GPP), VERIGENE Enteric Pathogens Test (EP), and ARIES C difficile Assay (RUO).

The assay is developed to be used in combination with clinical assessments, laboratory data, and epidemiological information to diagnose norovirus infections and identify them in the case of outbreaks.

Image: ARIES Norovirus Assay. Photo: courtesy of Luminex Corporation.